Exact Sciences saw the highest growth of 3.99% in patent filings in May and 3.99% in grants in April in Q2 2024. Compared to Q1 2024, Q2 2024 saw an increase in patent filings by 0.49% and grants by 3.99%. GlobalData’s DataBook provides a comprehensive analysis of Exact Sciences‘s patent filings and grants. Buy the databook here.
Exact Sciences has been focused on protecting inventions in United States(US) with 14 publications in Q2 2024
The United States(US) Patent Office dominates the patent filings and grants with nearly 47% filings and 54% grants. The United States(US), World Intellectual Property Organization(WIPO), European Patent Office(EPO), and China(CN) patent Office are among the top ten patent offices where Exact Sciences is filings its patents. Among the top granted patent authorities, Exact Sciences has 54% of its grants in United States(US), 15% in Australia(AU) and 8% in European Patent Office(EPO).
Exact Sciences stands in second position with respect to its patent publications among its competitors.
Patents related to genomics and rare diseases lead Exact Sciences's portfolio
Exact Sciences has the highest number of patents in genomics followed by, rare diseases and healthtech. For genomics, nearly 27% of patents were filed and 100% of patents were granted in Q2 2024.
Colorectal tumor related patents lead Exact Sciences portfolio followed by general surgery devices, and healthcare it
Exact Sciences has highest number of patents in colorectal tumor followed by general surgery devices, healthcare it, ovarian cancer.
For comprehensive analysis of Exact Sciences's filings and grants, buy the databook here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.